Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Androgen receptor signalling driving cancer stem cells (CSCs) state in triple-negative breast cancer

ABSTRACT: Androgen receptor signalling driving cancer stem cells (CSCs) state in triple-negative breast cancer

PROVIDER: PRJNA765586 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16019203_1.fastq.gz	Fastqsanger.gz
	SRR16019203_2.fastq.gz	Fastqsanger.gz
	SRR16019204_1.fastq.gz	Fastqsanger.gz
	SRR16019204_2.fastq.gz	Fastqsanger.gz
	SRR16019205_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 46

Similar Datasets

Androgen receptor signalling driving cancer stem cells (CSCs) state in triple-negative breast cancer

Project description:Therapeutic strategies that improve survival outcomes for advanced-stage breast cancers have proven a major clinical challenge. Here, we define an androgen receptor signalling network that governs the maintenance and de novo formation of cancer stem cells in triple-negative breast cancer. In response to chemotherapy, androgen receptor activation switches cells into a cancer stem cell state, while androgen receptor antagonism suppresses cancer stem cell formation and function. In vivo, we validate that the androgen receptor antagonist, seviteronel, significantly improves chemotherapy-mediated inhibition of primary and metastatic tumour growth.

2023-12-03 | GSE184647 | GEO

Transcriptome alteration of cancer stem cells (CSCs) and non-CSCs when CSCs were depleted in HNSCC

Project description:Transcriptome alteration of cancer stem cells (CSCs) and non-CSCs when CSCs were depleted in HNSCC

| PRJNA1083028 | ENA

Transcriptome alteration of cancer stem cells (CSCs) and non-CSCs when CSCs were depleted in HNSCC

Project description:To investigate the difference of signaling and cancer stemness activation molecules in CSCs and non-CSCs when Bmi1 was inhibited.

2025-03-04 | GSE260728 | GEO

SIX2 promotes cell plasticity via Wnt/beta-catenin signalling in androgen receptor independent prostate cancer (ATAC-seq)

Project description:The use of androgen receptor (AR) inhibitors in prostate cancer gives rise to increased cellular lineage plasticity resulting resistance to AR-targeted therapies. By examining the chromatin landscape of AR positive prostate cancer cells following exposure to the AR inhibitor enzalutamide, we have identified a novel regulator of cell plasticity, homeobox transcription factor SIX2, whose motif is enriched in accessible regions post-treatment. Our investigation demonstrates that depletion of SIX2 in androgen-independent PC-3 prostate cancer cells is sufficient to induce a switch from a stem-like to an epithelial state, leading to the reduction of key cancer-related properties such as proliferation, colony formation, and metastasis both in vitro and in vivo. These effects are mediated through downregulation of Wnt/β-catenin signalling pathway and subsequent reduced nuclear localization of β-catenin. Collectively, our findings provide compelling evidence that depletion of SIX2 may represent a promising strategy for overcoming cell plasticity mechanisms driving AR resistance in prostate cancer.

2024-03-19 | GSE235955 | GEO

SIX2 promotes cell plasticity via Wnt/beta-catenin signalling in androgen receptor independent prostate cancer (RNA-seq)

2024-03-19 | GSE235957 | GEO

SIX2 promotes cell plasticity via Wnt/beta-catenin signalling in androgen receptor independent prostate cancer (ChIP-seq)

2024-03-19 | GSE235956 | GEO

The effects of enzalutamide on androgen-dependent and androgen-independent prostate cancer cells.

Project description:To investigate the mechanisms of drug resistance and castration resistance in prostate cancer, we performed proteomic sequencing on androgen-dependent prostate cancer cells (LNCaP) and androgen-independent cells (AI) treated with enzalutamide.

2024-11-26 | PXD058261 |

Expression profile of lncRNAs in CSCs and non-CSCs of bladder cancer cell line

Project description:Bladder cancer stem cells (CSCs) contribute to tumorigenesis, recurrence and chemoresistance of bladder cancer. However, the molecular mechanisms underlying their self-renewal are poorly unknown. Long noncoding RNAs (lncRNAs) act as crucial regulators in a lot of human cancers, yet their potential roles and molecular mechanisms in bladder CSCs are poorly understood. The goal of this study is to identify the differentially expressed lncRNAs in bladder CSCs (UM-UC-3 4th spheres), its two differentiation sublines and bladder non-CSCs (UM-UC-3). Our study reveals that deregulation of lncRNAs is involved in the bladder CSCs.

2019-09-22 | GSE107857 | GEO

Expression profile of lncRNAs in CSCs and non-CSCs of bladder cancer cell line

Project description:Expression profile of lncRNAs in CSCs and non-CSCs of bladder cancer cell line

| PRJNA421726 | ENA

Loss of Feedback Regulation between FAM3B and Androgen Receptor Driving Prostate Cancer Progression

Project description:Loss of Feedback Regulation between FAM3B and Androgen Receptor Driving Prostate Cancer Progression

| PRJNA864771 | ENA